Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.61 |
| ▸ | PGR | P06401 | 8/20 | 0.61 |
| ▸ | AR | P10275 | 7/20 | 0.61 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24622441 | 1.00 | HIF1A (0.61) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL6523590 | 1.00 | HIF1A (0.61) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL12528263 | 0.91 | LMNA (0.59) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL2297384 | 0.88 | PGR (0.61) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL6522031 | 0.88 | PGR (0.61) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL2296903 | 0.88 | PGR (0.56) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL14680126 | 0.88 | PGR (0.56) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL12524081 | 0.88 | PGR (0.61) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL18971904 | 0.88 | PGR (0.61) | HIF1APGRARNR3C1CYP3A4 | |
| SCHEMBL16523019 | 0.87 | PGR (0.56) | HIF1APGRARNR3C1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4271387-A1 | NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCS CONTAINING AND USE THEREOF | Immunext, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-20230310634-A1 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | IMMUNEXT INC (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230310634-A1 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | IMMUNEXT INC (US) | 2023-10-05 | — | — | US | disclosed |
| WO-2022150637-A1 | NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOF | IMMUNEXT, INC. (US) | 2022-07-14 | — | — | WO | disclosed |
| WO-2022150637-A1 | NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOF | IMMUNEXT, INC. (US) | 2022-07-14 | — | — | WO | disclosed |
| EP-2475676-B1 | Pregnane derivatives condensed in the 16,17 position with an N-substituted isoxazolidine ring as anti-inflammatory agents | CHIESI FARM SPA (IT) | 2020-05-27 | — | — | EP | disclosed |
| US-10280193-B2 | Isoxazolidine derivatives | CHIESI FARMACEUTICI S.P.A. (IT) | 2019-05-07 | — | — | US | disclosed |
| US-10280193-B2 | Isoxazolidine derivatives | CHIESI FARMACEUTICI S.P.A. (IT) | 2019-05-07 | — | — | US | disclosed |
| US-20180066010-A1 | ISOXAZOLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2018-03-08 | — | — | US | disclosed |
| US-20180066010-A1 | ISOXAZOLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2018-03-08 | — | — | US | disclosed |
| US-20120238531-A1 | ISOXAZOLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-09-20 | — | — | US | disclosed |
| US-20120234316-A1 | ISOXAZOLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-09-20 | — | — | US | disclosed |
| US-20110201580-A1 | PYRROLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-08-18 | — | — | US | disclosed |
| US-20110201580-A1 | PYRROLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-08-18 | — | — | US | disclosed |
| US-20110201580-A1 | PYRROLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-08-18 | — | — | US | disclosed |
| WO-2011095535-A2 | PYRROLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011029547-A2 | PREGNANE DERIVATIVES CONDENSED IN THE 16, 17 POSITION WITH AN N-SUBSTITUTED ISOXAZOLIDINE RING AS ANTI-INFLAMMATORY AGENTS | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-03-17 | — | — | WO | disclosed |
| US-20110065678-A1 | ISOXAZOLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-03-17 | — | — | US | disclosed |
| US-20110065678-A1 | ISOXAZOLIDINE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-03-17 | — | — | US | disclosed |
| US-4232013-A | ANTIINFLAMMATORY AGENTS, RHEUMATISM | LARK S.P.A. (IT) | 1980-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120234316-A1 | ISOXAZOLIDINE DERIVATIVES | IL5, TSLP, SERPINA6 | HIF1A 646/4885PGR 2154/4885AR 1427/4885 |
| US-20110065678-A1 | ISOXAZOLIDINE DERIVATIVES | NR3C2, NR3C1, MC2R | HIF1A 2445/4885PGR 1856/4885AR 731/4885 |
| US-20120238531-A1 | ISOXAZOLIDINE DERIVATIVES | IL5, TSLP, LTB4R2 | HIF1A 815/4885PGR 2176/4885AR 1237/4885 |
| US-20180066010-A1 | ISOXAZOLIDINE DERIVATIVES | IL5, TSLP, SERPINA6 | HIF1A 646/4885PGR 2154/4885AR 1427/4885 |
| US-10280193-B2 | Isoxazolidine derivatives | IL5, TSLP, SERPINA6 | HIF1A 646/4885PGR 2154/4885AR 1427/4885 |
| US-20230310634-A1 | ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF | CD47, CLTA, FCGR2A | HIF1A 2042/4885PGR 2891/4885AR 1117/4885 |
| US-20110201580-A1 | PYRROLIDINE DERIVATIVES | IL5, TSLP, NR3C1 | HIF1A 2209/4885PGR 215/4885AR 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.